Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 7/20 | 0.61 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | FABP3 | P05413 | 5/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hexanoate SCHEMBL2761940 | 0.95 | BBOX1 (0.59) | BBOX1CA1FABP3NFKB1CES2 | |
| Dodecanoate SCHEMBL2762401 | 0.94 | BBOX1 (0.57) | BBOX1CA1FABP3CES2CES1 | |
| Octanoic Acid SCHEMBL2761784 | 0.94 | BBOX1 (0.57) | BBOX1CA1FABP3CES2CES1 | |
| Decanoic Acid SCHEMBL2762145 | 0.94 | BBOX1 (0.57) | BBOX1CA1FABP3CES2CES1 | |
| Heptanoate SCHEMBL2762665 | 0.94 | BBOX1 (0.57) | BBOX1CA1FABP3CES2CES1 | |
| Butyric Acid SCHEMBL143249 | 0.90 | BBOX1 (0.55) | BBOX1CA1FFAR3HDAC3HDAC1 | |
| Valeric Acid SCHEMBL145154 | 0.87 | BBOX1 (0.61) | BBOX1CA1FABP3 | |
| Valeric Acid SCHEMBL142194 | 0.87 | CA1 (0.53) | BBOX1CA1FABP3FFAR3HDAC3 | |
| Valeric Acid SCHEMBL143007 | 0.85 | CA1 (0.52) | BBOX1CA1FABP3NFKB1FFAR3 | |
| Valeric Acid SCHEMBL144677 | 0.85 | BBOX1 (0.62) | BBOX1CA1FABP3NFKB1FFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120058057-A1 | Anti-dandruff Agents | MERCK PATENT GMBH (DE) | 2012-03-08 | — | — | US | claimed |
| US-20120058057-A1 | Anti-dandruff Agents | MERCK PATENT GMBH (DE) | 2012-03-08 | — | — | US | disclosed |
| WO-2010136104-A2 | ANTI-DANDRUFF AGENTS | MERCK PATENT GMBH (DE) | 2010-12-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058057-A1 | Anti-dandruff Agents | POLR1C, ETF1, PIK3C3 | BBOX1 416/4885CA1 1037/4885FABP3 1675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.